Fund HoldingsLynx1 Capital Management LP

Total Portfolio Value
$865.53M
Total Bought
$264.80M
Total Sold
$71.75M
Net Transaction
+$193.05M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
GH RESEARCH PLC(GHRS)10,763,28813,263,288+2,500,000151,332356,51741.19%+205,185
AGIOS PHARMACEUTICALS INC(AGIO)2,611,5683,408,937+797,36988,349126,50614.62%+38,156
CULLINAN THERAPEUTICS INC(CGEM)8,963,5008,963,5000127,371163,22518.86%+35,854
C4 THERAPEUTICS INC(CCCC)6,998,9027,326,691+327,78918,40734,2163.95%+15,809
KORRO BIO INC(KRRO)1,538,2961,538,296017,41420,2752.34%+2,861
PRECISION BIOSCIENCES INC(DTIL)985,113950,466-34,6475,4187,4710.86%+2,053
PLIANT THERAPEUTICS INC(PLRX)01,798,070+1,798,07002,0500.24%+2,050
PROQR THRAPEUTICS N V
SHS EURO
68,486521,413+452,9271119700.11%+859
TRAWS PHARMA INC(TRAW)15,078559,470+544,392284720.05%+444
FOGHORN THERAPEUTICS INC(FHTX)061,588+61,58803010.03%+301
NEUPHORIA THERAPEUTICS INC875,328875,32803,5633,8250.44%+263
AVALO THERAPEUTICS INC(AVTX)010,100+10,10001870.02%+187
ABSCI CORPORATION21,24521,2450642460.03%+182
CG ONCOLOGY INC(CGON)31,59131,391-2002,1382,2300.26%+92
NUVATION BIO INC(NUVB)016,029+16,0290910.01%+91
VYNE THERAPEUTICS INC(YARW)1,628,7001,628,70009731,0600.12%+87
EUPRAXIA PHARMACEUTICALS INC(EPRX)010,000+10,0000660.01%+66
INHIBIKASE THERAPEUTICS INC(IKT)020,000+20,0000410.00%+41
BOLT BIOTHERAPEUTICS INC30,80030,80001241190.01%-6
IBIO INC(IBIO)68,0760-68,0761290-129
TSCAN THERAPEUTICS INC(TCRX)8,019,1488,019,14808,0997,8600.91%-240
WEREWOLF THERAPEUTICS INC(HOWL)657,786657,78605482370.03%-311
DESIGN THERAPEUTICS INC(DSGN)119,5160-119,5161,2720-1,272
ENTRADA THERAPEUTICS INC(TRDA)211,689178,606-33,0832,6721,3150.15%-1,357
PASSAGE BIO INC(PASG)623,704673,759+50,0554,8963,2880.38%-1,608
IMMATICS N.V(IMTX)216,97323,236-193,7372,1352350.03%-1,900
XENCOR INC(XNCR)536,39818,194-518,2046,4692930.03%-6,176
STOKE THERAPEUTICS INC(STOK)4,763,6734,038,404-725,269155,105132,13715.27%-22,969
DENALI THERAPEUTICS INC(DNLI)1,880,30311,658-1,868,64536,1023000.03%-35,802
Page 1 of 1
Lynx1 Capital Management LP — 13F Holdings — Q2 2026 | TickerTrail